Los Angeles Capital Management
FLGT icon

Los Angeles Capital Management’s Fulgent Genetics FLGT Stock Holding History

Los Angeles Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-178
Closed -$2.83K – 2384
2026
Q1 		$2.83K Sell
178
-8,130
-98% -$176K ﹤0.01% 2245
2025
Q4 		$188K Buy
+8,308
New +$216K ﹤0.01% 1262
2022
Q4 		– Sell
-10,183
Closed -$388K – 1214
2022
Q3 		$388K Sell
10,183
-9,431
-48% -$473K ﹤0.01% 994
2022
Q2 		$1.07M Buy
19,614
+8,388
+75% +$461K 0.01% 698
2022
Q1 		$701K Buy
11,226
+2,827
+34% +$186K ﹤0.01% 902
2021
Q4 		$845K Buy
8,399
+1,607
+24% +$141K ﹤0.01% 783
2021
Q3 		$611K Hold
6,792
– – ﹤0.01% 960
2021
Q2 		$626K Sell
6,792
-1,780
-21% -$142K ﹤0.01% 1073
2021
Q1 		$828K Sell
8,572
-15,727
-65% -$1.62M ﹤0.01% 984
2020
Q4 		$1.27M Buy
+24,299
New +$1.02M 0.01% 831

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Los Angeles Capital Management's FLGT Position: Q2 2026 in Review

Los Angeles Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 178 shares — an estimated $2.83K sold.

Los Angeles Capital Management first reported a position in FLGT in Q4 2020 and held it in 10 quarters. The position peaked at $1.27M in Q4 2020. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Los Angeles Capital Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 178 Fulgent Genetics shares in Q2 2026, an estimated $2.83K.
  • Los Angeles Capital Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 10 quarters.
  • Los Angeles Capital Management's Fulgent Genetics position peaked at $1.27M in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.